Huons Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HUONS, and what generic and branded alternatives to HUONS drugs are available?
HUONS has two approved drugs.
Drugs and US Patents for Huons
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Huons | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 212821-002 | Jun 15, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Huons | BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;SPINAL | 212822-001 | Dec 30, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Huons | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 212821-001 | May 7, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.